Skip to content
Trial Eligibility
Menu

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation

NCT05556902

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study in patients undergoing routine care epidural spinal cord stimulation (SCS) is to determine 1) whether SCS reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension, 2) whether higher baseline BP (i.e., hypertension) predicts reductions in pain following SCS, and finally 3) whether different SCS waveforms elicits stimulus-evoked compound action potentials (ECAPs) in spinal cord and at the cortex (electroencephalography, and magnetoenchphalography).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Blood Pressure
  • Low Back Pain
  • Hypertension

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 89 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Alabama at Birmingham
Last updated on ClinicalTrials.gov
August 11, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 1

  • University of Alabama at Birmingham · Birmingham, AL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.